Micro-Debridement with Collagenase SANTYL® Ointment

Inflammation can stall wound healing1
The presence of debris stimulates an influx of inflammatory cells, which can prolong the chronic wound cycle1
Chronic wounds show signs of inflammation1
Even after macroscopic (sharp or surgical) debridement, inflammatory processes continue to generate microscopic cellular debris, which prolongs the healing process8-15
- Histology shows coagulative tissue necrosis bordered by granulation tissue
Continuous, active micro-debridement
SANTYL® Ointment can help wounds progress from the inflammatory to the proliferative phase of healing
- Recent professional guidelines recommend continuous debridement to prepare the wound bed for healing16-18
- The continuous, active removal of necrotic materials with SANTYL® Ointment can help to prevent reaccumulation of the harmful debris that can prolong the healing process, thus allowing granulation to proceed and epithelialization to occur
Images courtesy of Robert Wiemer, DPM FACFAS; Mercy Health Center, Philadelphia, PA
Clinical Materials & ResourcesSANTYL® is a registered trademark of Healthpoint Biotherapeutics. Healthpoint Biotherapeutics and design is a registered trademark of Healthpoint Biotherapeutics.
© 2010 Healthpoint Canada ULC. All rights reserved.
The information on this site is intended for customers, patients, and healthcare professionals in Canada only. All information, including the Prescribing Information for Collagenase SANTYL® Ointment, abides by the laws, regulatory requirements, and medical practices for Canada only and may not be appropriate for use outside of Canada.
© 2010 Healthpoint Canada ULC. All rights reserved.
The information on this site is intended for customers, patients, and healthcare professionals in Canada only. All information, including the Prescribing Information for Collagenase SANTYL® Ointment, abides by the laws, regulatory requirements, and medical practices for Canada only and may not be appropriate for use outside of Canada.